Articles Archives - Page 129 of 715

WednesdayOct 18, 2023 9:45 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Takes Aim at Supply Chain Threats with Strategy to Bolster American Production of Tech-essential REEs

Strategic metals supply chain enterprise Ucore Rare Metals Inc. has developed its own proprietary solution for separating rare earth elements from their host ores in hopes of re-establishing a North American base for the REE supply chain During an era of international trade tensions over computer tech asset sourcing, Ucore aims to reduce Americans’ reliance on China for the REEs critical to modern technology ranging from cell phones and computers to electric vehicle batteries Ucore’s RapidSX(TM) REE processing solution is being demonstrated as advantageous over industry-standard CSX processes in side-by-side testing at Ucore’s facility in Ontario, Canada Ucore is preparing…

WednesdayOct 18, 2023 9:00 am

Jewelry Maker GEMXX Corp. (GEMZ) Notes Growing Success in Quarterly Financial Statement

Las Vegas-based jewelry maker GEMXX Corporation is reporting positive net revenues, and $0.00 in long-term liabilities, in the company’s recently released quarterly financial statement GEMXX is unique in that it mines its own gold resources and is making plans to operate the world’s largest Ammolite gemstone mine soon, all for its distinctively iridescent jewelry products Ammolite is a gemstone derived from the fossilized shells of large, extinct marine nautiluses — commercially mined in Alberta, Canada, and nowhere else in the world The company has a fully qualified Tier 1, Form 1A registration to raise up to $6 million through its…

TuesdayOct 17, 2023 10:30 am

Octane’s Medical Innovation Forum 2023: Shaping the Future of Healthcare through Entrepreneurial Intelligence

Industry experts, entrepreneurs, investors, and innovators from all areas of the medical industry are invited to attend the Octanes Medical Innovation Forum 2023 being held October 25-26, 2023, at the Irvine Marriott, Irvine, California. The two-day event is set to present a convergence of revolutionary technologies, advanced ideas, and the best industry expertise. Leveraging the transformative power of entrepreneurial intelligence, the event is dedicated to promoting a culture of innovation within the medical industry. The Octane’s Medical Innovation Forum 2023 will bring together luminaries, industry veterans, and disruptive startups, to explore innovations on the edge of medical transformation. As the…

TuesdayOct 17, 2023 9:45 am

Pest Control Innovator SenesTech Inc. (NASDAQ: SNES) Offers Unique Solution to Tackle the Spread of Rats Amid Growing Health Concerns

SenesTech Inc. is building worldwide influence as a rat population control solution that humanely and cost-effectively based on fertility control The company’s trademarked ContraPest(R) brand is designed to target rat pest populations large and small, as well as hard-to-get roof rodents, and is the only EPA-registered rat contraception product for both male and female rats The rebound in rat populations worldwide in the wake of the COVID pandemic and a recent report on the spread of the rat lungworm parasite (which can sicken or kill humans) have fostered a new sense of concern about rat-carried diseases SenesTech is expanding its…

TuesdayOct 17, 2023 9:00 am

SOHM, Inc. (SHMN) Bolsters Executive Team; Confident About Anticipated Developments and Opportunities

SOHM just announced the appointment of Wm. Dewey Rushing as the new VP-Quality His appointment follows the recent nomination of Dr. Krishna Bhat as the new Chief Medical Advisor and Dr. David Aguilar as the new COO It also follows the recently signed LOI for SOHM to acquire ABBIE stem cell disruptive technology and patents from CGA Intellectual Holdings Inc. SOHM (OTC: SHMN), a generic drug manufacturing and distributing innovator, is bolstering its executive team as it eyes the global nutraceuticals market, which is expected to post a CAGR of 9.4% between 2023 and 2030, and the global NSAID market…

MondayOct 16, 2023 12:00 pm

PaxMedica Inc. (NASDAQ: PXMD) Announces Gold Sponsorship for The BRAIN Foundation’s Synchrony Symposia 2023

The BRAIN Foundation's Synchrony Symposia is the first and only international symposium on translational research for Autism Spectrum Disorder (“ASD”) PaxMedica Chairman and CEO Howard Weisman says that participating at the symposium is pivotal in advancing and fostering autism research As a Gold Sponsor, PaxMedica will have purview to the symposium’s interdisciplinary discussions, insights, and research presentations, clinical roundtables, mentor-mentee sessions, and more PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of Autism Spectrum Disorder (“ASD”) and other serious conditions with intractable neurologic symptoms, recently announced its Gold Sponsorship…

MondayOct 16, 2023 11:15 am

Clene Inc. (NASDAQ: CLNN) Applies Patented Nanotechnology to Development of CNM-Au8(R), its Investigational Drug for ALS

In line with recent emphasis on the growing importance of nanotechnology in the US, Clene Nanomedicine innovated its investigational drug, CNM-Au8(R), using nanotechnology for the treatment of neurodegenerative disease Clene’s nanotechnological approach was recently recognized by the NINDS of NIH with a substantial grant to conduct an Expanded Access Protocol in ALS with CNM-Au8(R) Clene aims to file a New Drug Application for CNM-Au8(R) for ALS indications in the first half of 2024 October 2023 has turned into a month for the celebration of nanotechnology. On Wednesday, Oct. 4, 2023, three U.S.-based scientists, Moungi Bawendi, Louis Brus, and Aleksey Ekimov,…

MondayOct 16, 2023 10:30 am

Electronic Servitor Publication Network Inc. (XESP) Uses the Power of their Intelligent Interactive Platform to Help Clients Build and Retain Revenue

Digital engagement innovator Electronic Servitor Publication Network is devoted to using advanced automated, interactive technological solutions to help clients build their businesses and retain customers through powerful and cost-effective customer engagement The global customer engagement solutions market is expected to grow at a CAGR of 10.8 percent between 2022 and 2027, with a value of $32.2 billion, according to Customer Engagement Solutions Market analysis Electronic Servitor Publication Network bases its growth-as-a-service managed offering on its proprietary Digital Engagement Engine(TM) technology, which provides customer-tailored content, data analysis, niche identification, and prompt responsiveness The trending nature of advanced conversational intelligence has granted…

MondayOct 16, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Ongoing Diabetes Study Program to Examine its Patented DehydraTECH(TM) Technology with Launch of Human and Animal Studies for Oral GLP-1 Drugs

Lexaria recently announced its intention to launch new human and animal studies exploring its patented DehydraTECH(TM) technology on GLP-1 drugs for the potential treatment of diabetes The studies will build on what Lexaria has achieved so far since it started its diabetes-related studies in 2022 Its DehydraTECH-CBD demonstrated an almost three-fold improvement in drug delivery into the blood in its DIAB-A22-1 diabetes study compared to the DehydraTECH-CBD formulation used in its HYPER-H21-4 hypertension study These studies follow Lexaria’s announcement of its intention to study weight loss and diabetes control in a human population using DehydraTECH Lexaria Bioscience (NASDAQ: LEXX), a…

MondayOct 16, 2023 9:00 am

Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) Makes Significant Steps in Cementing Its Position among Top Critical Mineral Explorers with PCH Project

Appia recently entered into a definitive agreement to acquire up to a 70% interest in the 17,551.07-hectare PCH Project located in the State of Goiás, Brazil The company completed a due diligence program, with the initial results confirming widespread REE enrichment across the property Total rare earth element (“REE”) grades in numerous auger holes drilled at Target 4 ranged from 274 parts per million (“ppm”) to 16,648 ppm (1.66%), with an average of 1,291 ppm total REE, the results showed The PCH Project has a relatively higher content of heavy REE (“HREE”) in the deposit than Serra Verde, a large…

Site Search

Company Search

Category: Articles